Unilever (LON:ULVR) lags FTSE 350 with traders eyeing buyback and July results

Unilever rallies, closing in on analyst targets ahead of July earnings

July 7, 2026

London, July 7, 2026, 11:14 BST

  • Unilever PLC was up 3.05% at 4,695.75p, outpacing the FTSE 100’s 0.47% rise.
  • Tuesday’s jump means the stock now sits about 10% below the median 12-month analyst target of 5,160.27p.
  • Unilever’s Q2 and half-year numbers are set for July 28. In Q1, sales growth came mostly from higher volumes. Price growth cooled to 0.9%.

Unilever PLC shares jumped more than 3% on Tuesday, outpacing gains on the FTSE 100 ahead of the consumer group’s half-year earnings later this month. Hargreaves Lansdown delayed data had Unilever at 4,695.75p, up 139p. The FTSE 100 was up 0.47% at 10,701.46.

The stock is now sitting about 9.9% below the median 12-month analyst target of 5,160.27p on Investors Chronicle, after starting the week with a 13.2% gap from Monday’s 4,557p finish. That shift puts pressure on the next set of results, since the story is looking cleaner but tighter—investors now have to bet on volume growth, emerging markets and buybacks, with less of a cushion from a cheap price.

Market and forecast checkLatest / forecastGap from Tuesday price
Unilever trades at 4,695.75p, up 3.05%4,695.75p, +3.05%Beats FTSE 100 by 2.58 points
FTSE 100 is at 10,701.46, adding 0.47%10,701.46, +0.47%
Median analyst price target sits at 5,160.27p5,160.27pUp 9.9%
Top analyst call is 5,997.53p5,997.53p27.7% higher
Lowest analyst view is 3,801.86p3,801.86pThat’s down 19.0%
Trading Economics sees quarter-end at 4,534.07p4,534.07pOff 3.4%
Trading Economics 12-month view is 4,285.74p4,285.74pDown 8.7%

Prices come from Hargreaves Lansdown, with analyst targets via Investors Chronicle. Model forecasts are from Trading Economics. All percentage gaps use these sources.

The real test is the type of growth. Unilever posted Q1 underlying sales growth at 3.8%, missing the 4.0% full-year consensus listed on its investor site. Q1 volume growth hit 2.9%, ahead of the 2.1% consensus. Price growth came in at 0.9%, less than half the 1.9% expected for the full year.

Operating scorecardQ1 actualFY 2026 consensus / guide
Underlying sales growth3.8%4.0% consensus, company saying it expects at the low end of 4%-6%
Volume growth2.9%2.1% consensus
Price growth0.9%1.9% consensus
Underlying operating marginNot in Q1 statement20.1% consensus, company guides to slight improvement
EPS growthNot in Q1 statement3.4% consensus
Power Brands sales growth5.0%Ran ahead of group in Q1

Unilever Chief Executive Fernando Fernandez said in the Q1 update the group started the year with “volume-led growth driven by our Power Brands.” The July 28 results will show if that volume stuck in Q2. In Q1, underlying sales were up 5.7% in emerging markets but gained just 1.0% in developed ones. Europe slipped 0.9%. Investegate

Cost is still a headwind. Unilever’s July pre-close aide-memoire quoted the CFO saying full-year inflation would land between €750 million and €900 million. About half of net inflation was set to come from Home Care, mostly in emerging markets. The memo also said the productivity program had hit €750 million in savings by the end of Q1, close to an €800 million goal.

The Unilever portfolio question is still open. In March, Unilever reached a deal to merge its Foods unit with McCormick & Company Inc . Unilever gets $15.7 billion in cash, and its shareholders will own 65% of the new company. RBC’s James Edward Jones said then the deal structure “did not strike us as a smooth way” to turn Unilever into a pure play in household and personal care. Chris Beckett at Quilter Cheviot said the tie-up was “transformational for McCormick, but incremental for Unilever.” Reuters

Some investors flagged execution risk earlier. Barclays analyst Warren Ackerman said Fernandez should have “another year under his belt” before considering a food split. W1M portfolio manager Tineke Frikkee called the food demerger “not straightforward”—pointing to tax, scale and replacement-risk issues. Reuters

Some analysts point to the share count as a reason Unilever’s stock finds support. The company wrapped up a €1.5 billion buyback on June 5, picking up 30,703,780 ordinary shares for a total of €1,499,999,891. Unilever said cash from the Foods deal should help cover €6 billion in buybacks through 2026-2029, including this latest €1.5 billion round.

Looking at July 28, focus is on Q2 volume compared with the Q1 2.9% baseline, price growth versus the 0.9% gain from Q1, how Europe did after dropping in Q1, and Home Care margins since the last round of inflation guidance.

Konrad Wysocki

Konrad Wysocki is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Rzeszów, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Stock Market Today

  • Schroders Shares Flat at 587p After EU Clears Nuveen Takeover, Sells Benchmark Unit
    July 7, 2026, 6:43 AM EDT. Schroders PLC traded at 587p, mostly unchanged and just under Nuveen's 590p per share cash offer, after the European Commission approved the Nuveen deal. Schroders also offloaded its Benchmark financial planning unit to Söderberg & Partners as part of a shift in its wealth management strategy. The move gives Schroders a tidier balance sheet, but the stock barely moved. Nuveen's bid includes 590p in cash and possible dividends up to 22p a share. The acquisition is set to finish in Q4 2026 if it clears final approvals. Shareholders already backed the £9.9 billion takeover in April.